Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × viscum album peptide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Gemcitabine 328 Fluorouracil 84 Oxaliplatin 70 Capecitabine 66 Albumin-Bound Paclitaxel 64 Radiotherapy 62 130-nm albumin-bound paclitaxel 61 Leucovorin 52 Erlotinib Hydrochloride 46 Irinotecan 45 Cisplatin 43 Bevacizumab 30 Radiosurgery 29 pembrolizumab 25 Docetaxel 25 Taxes 23 Nivolumab 23 Cetuximab 20 Pancreaticoduodenectomy 17 Cyclophosphamide 15 Radiation 13 Drug Therapy 13 folfirinox 12 Endoscopic Ultrasound-Guided Fine Needle Aspiration 12 irinotecan sucrosofate 11 Sorafenib 11 S 1 (combination) 11 Paclitaxel 11 Neoadjuvant Therapy 11 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02948309 2023-01-13

MISTRAL

Karolinska University Hospital

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡